Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory Study

Summary

The goal of this clinical trial is to assess the concordance of treatment decisions made in multidisciplinary consultation meeting based on targeted biopsies alone or targeted biopsies associated with systematic biopsies in patients with suspected prostate cancer.

Eligibility

Inclusion Criteria:

* Patient, male, aged between ≥ 50 and ≤ 75 years old
* Patient with no history of prostate biopsy
* Patient with a PSA greater than 4 and/or a pathological digital rectal examination
* Patient having an MRI of interpretable quality carried out within the HPA
* Patient with a single lesion with a PI-RADS score ≥ 3
* Affiliated patient or beneficiary of a social security scheme
* French-speaking patient who signed an informed consent

Exclusion Criteria:

* Patient with a contraindication to MRI
* Patient with multiple targets
* Patient with lesions with PI-RADS score 1 and 2
* Patient on long-term anticoagulants and unable to stop it
* Patient already included in another study
* Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
* Patient hospitalized without consent

Conditions2

Browse More Trials